Spots Global Cancer Trial Database for Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Adjuvant High-intensity Interval Training During Chemotherapy in Metastatic Prostate Cancer Patients

Official Title: Pilot Study of a Randomized Chemo-periodized Adjuvant High-Intensity Interval Training Intervention to Improve Chemotherapy Tolerance in Men With Metastatic Prostate Cancer

Study ID: NCT05156372

Conditions

Prostate Cancer Metastatic

Castrate Resistant Prostate Cancer

Metastatic Prostate Cancer

Metastatic Prostate Adenocarcinoma

Interventions

High Intensity Interval Training

Study Description

Brief Summary: This study aims to examine the use of high-intensity interval training (HIIT) and resistance training on docetaxel chemotherapy tolerability and toxicity in metastatic prostate cancer.

Detailed Description: Exercise has been shown to decrease tumor progression and mitigate treatment-related side effects, such as fatigue, while increasing physical fitness. In this study, investigators will test the effects of a high intensity interval training and resistance exercise program on how patients with metastatic prostate cancer tolerate docetaxel chemotherapy. Participants assigned to the exercise intervention will be asked to meet with a personal trainer 2-3 times per week for supervised exercise sessions. All participants will be asked to complete electronic questionnaires during their chemotherapy sessions that ask about their physical and mental wellbeing.